Balapiravir 25mg 25mg | Purity Not Available
Adooq Bioscience
Balapiravir (R1626, RG1626) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479).
More Information Supplier PageSearch Results
Balapiravir 10mg 10mg | Purity Not Available
Adooq Bioscience
Balapiravir (R1626, RG1626) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479).
More Information Supplier PageBIBX 1382 5mg 5mg | Purity Not Available
Adooq Bioscience
BIBX 1382 is a cell-permeable pyrimidopyrimidine compound that acts as a potent, reversible, ATP-competitive, and highly selective inhibitor of EGFR.
More Information Supplier PageBIBX 1382 25mg 25mg | Purity Not Available
Adooq Bioscience
BIBX 1382 is a cell-permeable pyrimidopyrimidine compound that acts as a potent, reversible, ATP-competitive, and highly selective inhibitor of EGFR.
More Information Supplier PageBIBX 1382 10mg 10mg | Purity Not Available
Adooq Bioscience
BIBX 1382 is a cell-permeable pyrimidopyrimidine compound that acts as a potent, reversible, ATP-competitive, and highly selective inhibitor of EGFR.
More Information Supplier PageBRAF inhibitor 5mg 5mg | Purity Not Available
Adooq Bioscience
BRAF inhibitor 25mg 25mg | Purity Not Available
Adooq Bioscience
BRAF inhibitor 10mg 10mg | Purity Not Available
Adooq Bioscience
Boceprevir 50mg 50mg | Purity Not Available
Adooq Bioscience
Boceprevir is a protease inhibitor used as a treatment for hepatitis C genotype 1.
More Information Supplier PageBay 60-7550 5mg 5mg | Purity Not Available
Adooq Bioscience
BAY 60-7550 is a potent PDE2 inhibitor with IC50 values of 2.0 nM (bovine) and 4.7 nM (human).
More Information Supplier Page